John Cazale, MD
Orthopaedic Surgery · Metairie, LANPI 1730180449
Payments from drug & device makers
Across 26 payments — averaging $19.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- BD$116
- Johnson & Johnson$111
- Ferring Pharmaceuticals Inc.$49
- Abbott$30
- Boston Scientific$28
- Sanofi-aventis U.S. LLC$28
- plus $150 from 9 others
What the payments were for
- Food & beverage$512100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| BD | 1 | $116 |
| Johnson & Johnson | 8 | $111 |
| Ferring Pharmaceuticals Inc. | 3 | $49 |
| Abbott | 2 | $30 |
| Boston Scientific | 1 | $28 |
| Sanofi-aventis U.S. LLC | 2 | $28 |
| Bioventus LLC | 1 | $28 |
| Pacira Pharmaceuticals Incorporated | 1 | $27 |
| Innovation Technologies Inc | 1 | $18 |
| Vertex | 1 | $15 |
| Fidia Pharma USA Inc. | 1 | $14 |
| Medtronic | 1 | $14 |
| AbbVie | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Avanos Medical | 1 | $11 |
How this compares
$512 in reported general payments places this provider in the 20th percentile of 286 orthopaedic surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 658 | $5,213 |
| Celecoxib | 217 | $4,564 |
| Diclofenac Sodium | 232 | $2,291 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 256 | $2,022 |
| Methylprednisolone | 259 | $1,836 |
| Etodolac | 53 | $1,672 |
| Tramadol Hcl | 168 | $767 |
| Methocarbamol | 96 | $585 |
| Ibuprofen | 37 | $404 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 70 | $403 |
| Cyclobenzaprine Hcl | 23 | $194 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 14 | $164 |
| Pregabalin | 20 | $160 |
| Doxycycline Hyclate | 24 | $138 |
| Meloxicam | 59 | $109 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Metairie
- Ralph JuniusMetairie$158K
- Ryan RoubionMetairie$48K
- Keith MelanconMetairie$27K
- Pierce NunleyShreveport$3.8M
- Christopher HarrodBaton Rouge$3.1M
- Vinod DasaKenner$1.9M
- Jorge IsazaBaton Rouge$1.2M
- Robert ZuraNew Orleans$792K
- Kevin McCarthyBaton Rouge$714K
- Fernando SanchezNew Orleans$655K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.